TCL Archive ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication February 17, 2012
TCL Archive The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six. June 23, 2000